Belgian GreenTech company H2WIN has developed H2GREEN: an ingenious system to make hydrogen production 100% renewable, more efficient, less expensive, and less energy consuming. Based in Nivelles, H2WIN drew inspiration from nature’s own ancient methods of generating energy: photosynthesis. The company is currently looking for funding to finance the next steps towards industrial-scale production.
Many argue that young companies have little need for a Chief Financial Officer (CFO). They would say that CFOs are unnecessary and costly add-ons early on when a business’ financial needs can be satisfied through outsourcing or by a more junior member of staff. However a CFO brings a deeper and more strategic financial perspective which can help a company outgrow the competition. So, is delaying CFO recruitment a sensible budgetary decision or an expensive mistake?
Researchers have identified the bitter substances in Belgian endives and chicory. Using the gene-editing technique CRISPR/Cas9, they have also succeeded in eliminating them. The result is a less bitter vegetable that may be more appetizing to children and adults alike. The catch? Outdated EU gene editing laws present a major roadblock for any company looking to actually produce the vegetables in Europe.
Ghent, Belgium, 27 January 2022 - V-Bio Ventures, a venture capital company that focuses specifically on the segment of young pioneering biotech companies, has increased the capital of its second fund V-Bio Fund 2 to 96 million euros. The fundraising will continue for several months, and the fund managers expect the target of EUR 100 million will be achieved.
In recent public discussions on economic progress, people have been asking: is infinite growth really the best way to measure economic success? With a background in biology, having entered the investment world in the year 2000, Christina Takke found this an intriguing question best viewed through the metaphor of life in a test tube versus a real ecosystem.
Ghent, Belgium, 20 January 2022 – Dr. Ann Van Gysel has been appointed as CEO of the flanders.healthTech spearhead cluster. She will lead the cluster, which brings together personalized and digital medicine and healthcare technology in Flanders, and supports the development and implementation of new technologies in the Flemish healthcare sector.
Mechelen, Belgium, January 25, 2022 - Belgian company ElmediX is developing intensive and controlled heat treatments for the treatment of cancer. A new capital injection of 4M euros brings the total to almost 12M euros (including VLAIO research grants worth 1.8M euros) and accelerates the trajectory of this innovative MedTech company.
As part of the ‘Health & Biotech Valley of Tomorrow’ initiative, the Belgian government recently signed a charter together with stakeholders from academia and industry, pledging to cement Belgium’s status as a biotech powerhouse in the next 10 to 20 years. Over the next few months, working groups will translate recommendations of a consultancy report into a concrete strategic plan for the future of the country. Amongst other topics, experts will evaluate ways to encourage more collaboration, provide financial stimuli, and make better use of health data.
Belgian GreenTech company H2WIN has developed H2GREEN: an ingenious system to make hydrogen production 100% renewable, more efficient, less expensive, and less energy consuming. Based in Nivelles, H2WIN drew inspiration from nature’s own ancient methods of generating energy: photosynthesis. The company is currently looking for funding to finance the next steps towards industrial-scale production.
Many argue that young companies have little need for a Chief Financial Officer (CFO). They would say that CFOs are unnecessary and costly add-ons early on when a business’ financial needs can be satisfied through outsourcing or by a more junior member of staff. However a CFO brings a deeper and more strategic financial perspective which can help a company outgrow the competition. So, is delaying CFO recruitment a sensible budgetary decision or an expensive mistake?
Researchers have identified the bitter substances in Belgian endives and chicory. Using the gene-editing technique CRISPR/Cas9, they have also succeeded in eliminating them. The result is a less bitter vegetable that may be more appetizing to children and adults alike. The catch? Outdated EU gene editing laws present a major roadblock for any company looking to actually produce the vegetables in Europe.
Ghent, Belgium, 27 January 2022 - V-Bio Ventures, a venture capital company that focuses specifically on the segment of young pioneering biotech companies, has increased the capital of its second fund V-Bio Fund 2 to 96 million euros. The fundraising will continue for several months, and the fund managers expect the target of EUR 100 million will be achieved.
In recent public discussions on economic progress, people have been asking: is infinite growth really the best way to measure economic success? With a background in biology, having entered the investment world in the year 2000, Christina Takke found this an intriguing question best viewed through the metaphor of life in a test tube versus a real ecosystem.
Ghent, Belgium, 20 January 2022 – Dr. Ann Van Gysel has been appointed as CEO of the flanders.healthTech spearhead cluster. She will lead the cluster, which brings together personalized and digital medicine and healthcare technology in Flanders, and supports the development and implementation of new technologies in the Flemish healthcare sector.
Mechelen, Belgium, January 25, 2022 - Belgian company ElmediX is developing intensive and controlled heat treatments for the treatment of cancer. A new capital injection of 4M euros brings the total to almost 12M euros (including VLAIO research grants worth 1.8M euros) and accelerates the trajectory of this innovative MedTech company.
As part of the ‘Health & Biotech Valley of Tomorrow’ initiative, the Belgian government recently signed a charter together with stakeholders from academia and industry, pledging to cement Belgium’s status as a biotech powerhouse in the next 10 to 20 years. Over the next few months, working groups will translate recommendations of a consultancy report into a concrete strategic plan for the future of the country. Amongst other topics, experts will evaluate ways to encourage more collaboration, provide financial stimuli, and make better use of health data.